FDA Webview
X
about-us-banner

Pay Per View

Home / Pay Per View

Hold Lifted on Lung/Breast Cancer ADC Drug

[ Price : $8.95]

FDA lifts a partial clinical hold on a MediLink Therapeutics and BioNTech Phase 1 trial evaluating BNT326/YL202 (NCT05653752), a H...

Guide on ANDA Meeting Requests

[ Price : $8.95]

FDA posts a final guidance entitled Product-Specific Guidance (PSG) Meetings Between FDA and ANDA Applicants Under GDUFA.

Vaccines Panel to Discuss Pertussis Study Model

[ Price : $8.95]

Federal Register notice: FDA announces a 9/20 Vaccines and Related Biological Products Advisory Committee to discuss controlled hu...

FDA Denies Petition Seeking to Block Liquidia NDA

[ Price : $8.95]

FDA rejects a United Therapeutics citizen petition that asked it to withdraw tentative approval of a Liquidia Technologies NDA for...

Guard Medical Gets Clearance for NPseal

[ Price : $8.95]

FDA clears a Guard Medical 510(k) for additional large sizes of surgical incision closures (wounds up to 25cm) for treatment with ...

Class 2 for Nucleic Acid Covid Tests

[ Price : $8.95]

Federal Register notice: FDA classifies into Class 2 devices that are intended to detect and identify nucleic acid targets in resp...

At-Home Test Authorized for Syphilis

[ Price : $8.95]

FDA grants a de novo marketing authorization to NOWDiagnostics for its at-home First To Know Syphilis Test.

Catheter Separation Devices are Class 2

[ Price : $8.95]

Federal Register notice: FDA classifies intravenous catheter force-activated separation devices into Class 2 (special controls).

Febrile Illness Detection Devices are Class 2

[ Price : $8.95]

Federal Register notice: FDA classifies into Class 2 devices that are intended to detect and identify selected microbial agents th...

iRhythm Hit with 483 After July Inspection

[ Price : $8.95]

FDA issues iRhythm Technologies a Form FDA-483 after an inspection last month cited three GMP deficiencies.